Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

One of the main challenges when it comes to effective diagnosis and treatment for ovarian cancer is the complexity of identifying symptoms. This is largely due to the fact that most ovarian cancer ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...

The moment that we were told that they were raising this money, my wife and I got on our knees in our bedroom and we prayed,” ...

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Scientists at The University of Texas at El Paso have identified a promising new target in the battle against high-grade ...

FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

Dr. Erin Stevens of Green Bay recently became the first physician in northeast Wisconsin to use Cytalux in an operation, ...